Frequently bought together

Brand : DOGMATIL

DOGMATIL 200MG TAB

22.5

Sku : I-001705
Key features
Dogmatil Fort Scored tablet 200 mg is a prescription medicine containing sulpiride, supplied as a scored tablet. It works by blocking dopamine D2 receptors, with effects that vary by dose to help regulate dopamine activity in the brain. It is used for the treatment of schizophrenia and other acute or chronic psychotic disorders. This pack contains 12 scored tablets of 200 mg strength.
- Brand: DOGMATIL
- Active Ingredient: SULPIRIDE
- Strength: 200mg
- Dosage Form: Scored tablet
- Pack Size: 12 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Psychiatric
- Pharmacological Group: Antipsychotics
- Drug Class: Substituted benzamide antipsychotic (atypical)
- Manufacturer: Delpharm Dijon
- Country of Origin: France
- SFDA Registration No.: 5-90-82
- Shelf Life: 36 months
- Storage: store below 30°c
- Psych Class: Antipsychotic-Atypical
- Controlled Substance: No

Frequently bought together

Description

Specification

Indications

Approved Uses

Schizophrenia and other acute/chronic psychotic disorders (antipsychotic indication).

Side Effects

Common Side Effects

Hyperprolactinemia (amenorrhea, galactorrhea, gynecomastia, sexual dysfunction), extrapyramidal symptoms (e.g., akathisia, tremor, rigidity), sedation/drowsiness or insomnia, weight gain, constipation, dry mouth; rash can occur.

Side Effect Frequency

Hyperprolactinemia and related endocrine effects (e.g., galactorrhea, amenorrhea, gynecomastia/sexual dysfunction) and extrapyramidal symptoms (e.g., akathisia, dystonia/parkinsonism) are common; sedation/drowsiness, insomnia, constipation and weight gain are common; orthostatic hypotension and QT prolongation/ventricular arrhythmias are uncommon to rare; neuroleptic malignant syndrome, tardive dyskinesia, seizures, and blood dyscrasias (e.g., agranulocytosis) are rare.

Drug Interactions

Major interactions: levodopa/dopamine agonists (reciprocal antagonism); alcohol/CNS depressants (additive sedation); antihypertensives (additive hypotension); QT‑prolonging drugs (additive torsades risk); lithium (increased neurotoxicity/EPS risk); antacids/sucralfate (reduced sulpiride absorption-separate dosing).

Alcohol Interaction

Avoid

Special Populations

Breastfeeding

Avoid in mothers with history of major depression; use with caution otherwise; increases prolactin and may cause galactorrhea

Storage & Patient Advice

Overdose

Expected overdose effects: sedation, hypotension, extrapyramidal symptoms, agitation/confusion, and potential QT prolongation/ventricular arrhythmias (including torsades) and coma; management is supportive (airway/ventilation, IV fluids/vasopressors as needed), consider activated charcoal if early, and continuous ECG/cardiac monitoring-no specific antidote.

Pharmacology

Mechanism of Action

Dopamine D2 (and to a lesser extent D3) receptor antagonist; at low doses preferential presynaptic autoreceptor blockade may increase dopaminergic transmission, while higher doses block postsynaptic receptors producing antipsychotic effects.